APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fungal Drugs for Treatment of Tinea

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Fungal Drugs for Treatment of Tinea Industry Growth and Trends Forecast to 2032

20 December 2025124 pages

Choose your research edition.

Industry ResearchFungal Drugs for Treatment of Tinea Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Fungal Drugs for Treatment of Tinea Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Fungal Drugs for Treatment of Tinea Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fungal Drugs for Treatment of Tinea Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Fungal Drugs for Treatment of Tinea Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

According to APO Research, the global Fungal Drugs for Treatment of Tinea market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Fungal Drugs for Treatment of Tinea is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Fungal Drugs for Treatment of Tinea is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fungal Drugs for Treatment of Tinea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Fungal Drugs for Treatment of Tinea market include Tianjin Lisheng Pharmaceuticals, Teva Pharmaceuticals, Shanghai Modern Hasen (Shangqiu) Pharmaceuticals, Shandong Qilu Pharmaceuticals, Shandong Luoxin Pharmaceuticals, Shandong Jingwei Pharmaceutical, Sandoz, Johnson & Johnson and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Fungal Drugs for Treatment of Tinea market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fungal Drugs for Treatment of Tinea market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fungal Drugs for Treatment of Tinea market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fungal Drugs for Treatment of Tinea.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Fungal Drugs for Treatment of Tinea market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fungal Drugs for Treatment of Tinea Market by Company

Tianjin Lisheng Pharmaceuticals

Teva Pharmaceuticals

Shanghai Modern Hasen (Shangqiu) Pharmaceuticals

Shandong Qilu Pharmaceuticals

Shandong Luoxin Pharmaceuticals

Shandong Jingwei Pharmaceutical

Sandoz

Johnson & Johnson

Novartis

Jiangsu Zhiyuan Pharmaceutical

Jiangsu Yunyang Group Pharmaceuticals

Hubei Hengan Fulin

Hainan Kangzhi Pharmaceuticals

Harbin Sanlian Pharmaceuticals

Guilin Huaxin Pharmaceuticals

GSK

Chengdu Beite Pharmaceuticals

Bayer

Ultratech India

Perrigo

Padagis

Kaken Pharmaceutical

Gufic Biosciences

Galderma

Bausch Health

Fungal Drugs for Treatment of Tinea Segment by Type

Topical Drugs

Oral Drugs

Fungal Drugs for Treatment of Tinea Segment by Application

Hospital Pharmacy

Online

Retail Pharmacy

Fungal Drugs for Treatment of Tinea Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Drugs for Treatment of Tinea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fungal Drugs for Treatment of Tinea and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Drugs for Treatment of Tinea.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Fungal Drugs for Treatment of Tinea companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Fungal Drugs for Treatment of Tinea Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2021-2026) Table 4. Global Fungal Drugs for Treatment of Tinea Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2027-2032) Table 6. Global Fungal Drugs for Treatment of Tinea Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Fungal Drugs for Treatment of Tinea Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Fungal Drugs for Treatment of Tinea Market Size Share by Type (2021-2026) Table 9. Global Fungal Drugs for Treatment of Tinea Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Fungal Drugs for Treatment of Tinea Market Size Share Forecasted by Type (2027-2032) Table 11. North America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Fungal Drugs for Treatment of Tinea Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Fungal Drugs for Treatment of Tinea Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Fungal Drugs for Treatment of Tinea Market Size Share by Application (2021-2026) Table 24. Global Fungal Drugs for Treatment of Tinea Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Fungal Drugs for Treatment of Tinea Market Size Share Forecasted by Application (2027-2032) Table 26. North America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Fungal Drugs for Treatment of Tinea Industry Trends Table 37. Fungal Drugs for Treatment of Tinea Industry Drivers Table 38. Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges Table 39. Fungal Drugs for Treatment of Tinea Industry Restraints Table 40. Global Fungal Drugs for Treatment of Tinea Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Fungal Drugs for Treatment of Tinea Revenue Market Share by Company (2021-2026) Table 42. Global Fungal Drugs for Treatment of Tinea Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Fungal Drugs for Treatment of Tinea Key Company Headquarters & Area Served Table 44. Global Fungal Drugs for Treatment of Tinea Company, Product Type & Application Table 45. Global Fungal Drugs for Treatment of Tinea Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Fungal Drugs for Treatment of Tinea by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Tianjin Lisheng Pharmaceuticals Company Information Table 49. Tianjin Lisheng Pharmaceuticals Business Overview Table 50. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 52. Tianjin Lisheng Pharmaceuticals Recent Development Table 53. Teva Pharmaceuticals Company Information Table 54. Teva Pharmaceuticals Business Overview Table 55. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 57. Teva Pharmaceuticals Recent Development Table 58. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information Table 59. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview Table 60. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 62. Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Development Table 63. Shandong Qilu Pharmaceuticals Company Information Table 64. Shandong Qilu Pharmaceuticals Business Overview Table 65. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 67. Shandong Qilu Pharmaceuticals Recent Development Table 68. Shandong Luoxin Pharmaceuticals Company Information Table 69. Shandong Luoxin Pharmaceuticals Business Overview Table 70. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 72. Shandong Luoxin Pharmaceuticals Recent Development Table 73. Shandong Jingwei Pharmaceutical Company Information Table 74. Shandong Jingwei Pharmaceutical Business Overview Table 75. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 77. Shandong Jingwei Pharmaceutical Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio Table 82. Sandoz Recent Development Table 83. Johnson & Johnson Company Information Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio Table 87. Johnson & Johnson Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novartis Fungal Drugs for Treatment of Tinea Product Portfolio Table 92. Novartis Recent Development Table 93. Jiangsu Zhiyuan Pharmaceutical Company Information Table 94. Jiangsu Zhiyuan Pharmaceutical Business Overview Table 95. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 97. Jiangsu Zhiyuan Pharmaceutical Recent Development Table 98. Jiangsu Yunyang Group Pharmaceuticals Company Information Table 99. Jiangsu Yunyang Group Pharmaceuticals Business Overview Table 100. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 102. Jiangsu Yunyang Group Pharmaceuticals Recent Development Table 103. Hubei Hengan Fulin Company Information Table 104. Hubei Hengan Fulin Business Overview Table 105. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio Table 107. Hubei Hengan Fulin Recent Development Table 108. Hainan Kangzhi Pharmaceuticals Company Information Table 109. Hainan Kangzhi Pharmaceuticals Business Overview Table 110. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 112. Hainan Kangzhi Pharmaceuticals Recent Development Table 113. Harbin Sanlian Pharmaceuticals Company Information Table 114. Harbin Sanlian Pharmaceuticals Business Overview Table 115. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 117. Harbin Sanlian Pharmaceuticals Recent Development Table 118. Guilin Huaxin Pharmaceuticals Company Information Table 119. Guilin Huaxin Pharmaceuticals Business Overview Table 120. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 122. Guilin Huaxin Pharmaceuticals Recent Development Table 123. GSK Company Information Table 124. GSK Business Overview Table 125. GSK Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. GSK Fungal Drugs for Treatment of Tinea Product Portfolio Table 127. GSK Recent Development Table 128. Chengdu Beite Pharmaceuticals Company Information Table 129. Chengdu Beite Pharmaceuticals Business Overview Table 130. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio Table 132. Chengdu Beite Pharmaceuticals Recent Development Table 133. Bayer Company Information Table 134. Bayer Business Overview Table 135. Bayer Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Bayer Fungal Drugs for Treatment of Tinea Product Portfolio Table 137. Bayer Recent Development Table 138. Ultratech India Company Information Table 139. Ultratech India Business Overview Table 140. Ultratech India Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio Table 142. Ultratech India Recent Development Table 143. Perrigo Company Information Table 144. Perrigo Business Overview Table 145. Perrigo Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio Table 147. Perrigo Recent Development Table 148. Padagis Company Information Table 149. Padagis Business Overview Table 150. Padagis Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Padagis Fungal Drugs for Treatment of Tinea Product Portfolio Table 152. Padagis Recent Development Table 153. Kaken Pharmaceutical Company Information Table 154. Kaken Pharmaceutical Business Overview Table 155. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio Table 157. Kaken Pharmaceutical Recent Development Table 158. Gufic Biosciences Company Information Table 159. Gufic Biosciences Business Overview Table 160. Gufic Biosciences Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio Table 162. Gufic Biosciences Recent Development Table 163. Galderma Company Information Table 164. Galderma Business Overview Table 165. Galderma Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Galderma Fungal Drugs for Treatment of Tinea Product Portfolio Table 167. Galderma Recent Development Table 168. Bausch Health Company Information Table 169. Bausch Health Business Overview Table 170. Bausch Health Fungal Drugs for Treatment of Tinea Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio Table 172. Bausch Health Recent Development Table 173. North America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2026) Table 176. North America Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Fungal Drugs for Treatment of Tinea Market Share Forecast by Country (2027-2032) Table 178. Europe Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2026) Table 181. Europe Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Fungal Drugs for Treatment of Tinea Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2026) Table 186. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Share Forecast by Country (2027-2032) Table 188. Latin America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2026) Table 191. Latin America Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Fungal Drugs for Treatment of Tinea Market Share Forecast by Country (2027-2032) Table 193. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2026) Table 196. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Share Forecast by Country (2027-2032) Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Fungal Drugs for Treatment of Tinea Product Image Figure 3. Global Fungal Drugs for Treatment of Tinea Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Fungal Drugs for Treatment of Tinea Market Size (2021-2032) & (US$ Million) Figure 5. Global Fungal Drugs for Treatment of Tinea Market Share by Region: 2025 VS 2032 Figure 6. Global Fungal Drugs for Treatment of Tinea Market Share by Region (2021-2032) Figure 7. North America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Topical Drugs Image Figure 13. Global Topical Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Oral Drugs Image Figure 15. Global Oral Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Fungal Drugs for Treatment of Tinea Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Fungal Drugs for Treatment of Tinea Market Share by Type 2025 VS 2032 Figure 18. North America Fungal Drugs for Treatment of Tinea Market Size Share by Type (2021-2032) Figure 19. Europe Fungal Drugs for Treatment of Tinea Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Share by Type (2021-2032) Figure 21. Latin America Fungal Drugs for Treatment of Tinea Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Share by Type (2021-2032) Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Online Image Figure 26. Global Online Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Fungal Drugs for Treatment of Tinea Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Fungal Drugs for Treatment of Tinea Market Share by Application 2025 VS 2032 Figure 31. North America Fungal Drugs for Treatment of Tinea Market Size Share by Application (2021-2032) Figure 32. Europe Fungal Drugs for Treatment of Tinea Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Share by Application (2021-2032) Figure 34. Latin America Fungal Drugs for Treatment of Tinea Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Fungal Drugs for Treatment of Tinea Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Fungal Drugs for Treatment of Tinea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Fungal Drugs for Treatment of Tinea Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032) Figure 41. Europe Fungal Drugs for Treatment of Tinea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Fungal Drugs for Treatment of Tinea Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032) Figure 44. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032) Figure 47. Latin America Fungal Drugs for Treatment of Tinea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Fungal Drugs for Treatment of Tinea Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032) Figure 50. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Fungal Drugs for Treatment of Tinea Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Drugs
  • Oral Drugs
Applications
  • Hospital Pharmacy
  • Online
  • Retail Pharmacy
Companies covered
  • Tianjin Lisheng Pharmaceuticals
  • Teva Pharmaceuticals
  • Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
  • Shandong Qilu Pharmaceuticals
  • Shandong Luoxin Pharmaceuticals
  • Shandong Jingwei Pharmaceutical
  • Sandoz
  • Johnson & Johnson
  • Novartis
  • Jiangsu Zhiyuan Pharmaceutical
  • Jiangsu Yunyang Group Pharmaceuticals
  • Hubei Hengan Fulin
  • Hainan Kangzhi Pharmaceuticals
  • Harbin Sanlian Pharmaceuticals
  • Guilin Huaxin Pharmaceuticals
  • GSK
  • Chengdu Beite Pharmaceuticals
  • Bayer
  • Ultratech India
  • Perrigo
  • Padagis
  • Kaken Pharmaceutical
  • Gufic Biosciences
  • Galderma
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Fungal Drugs for Treatment of Tinea Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2032)
  5. 1.4.1 Global Fungal Drugs for Treatment of Tinea Market Size by Region (2021-2026)
  6. 1.4.2 Global Fungal Drugs for Treatment of Tinea Market Size by Region (2027-2032)
  7. 1.5 Key Regions Fungal Drugs for Treatment of Tinea Market Size (2021-2032)
  8. 1.5.1 North America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Growth Rate (2021-2032)
2 Fungal Drugs for Treatment of Tinea Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Topical Drugs
  3. 2.1.2 Oral Drugs
  4. 2.2 Global Fungal Drugs for Treatment of Tinea Market Size by Type
  5. 2.2.1 Global Fungal Drugs for Treatment of Tinea Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Fungal Drugs for Treatment of Tinea Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Fungal Drugs for Treatment of Tinea Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Fungal Drugs for Treatment of Tinea Market Size by Regions
  9. 2.3.1 North America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Breakdown by Type (2021-2026)
3 Fungal Drugs for Treatment of Tinea Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacy
  3. 3.1.2 Online
  4. 3.1.3 Retail Pharmacy
  5. 3.2 Global Fungal Drugs for Treatment of Tinea Market Size by Application
  6. 3.2.1 Global Fungal Drugs for Treatment of Tinea Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Fungal Drugs for Treatment of Tinea Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Fungal Drugs for Treatment of Tinea Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Fungal Drugs for Treatment of Tinea Market Size by Regions
  10. 3.3.1 North America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Fungal Drugs for Treatment of Tinea Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Fungal Drugs for Treatment of Tinea Industry Trends
  2. 4.2 Fungal Drugs for Treatment of Tinea Industry Drivers
  3. 4.3 Fungal Drugs for Treatment of Tinea Industry Opportunities and Challenges
  4. 4.4 Fungal Drugs for Treatment of Tinea Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Fungal Drugs for Treatment of Tinea Revenue (2021-2026)
  2. 5.2 Global Fungal Drugs for Treatment of Tinea Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Fungal Drugs for Treatment of Tinea Key Company Headquarters & Area Served
  4. 5.4 Global Fungal Drugs for Treatment of Tinea Company, Product Type & Application
  5. 5.5 Global Fungal Drugs for Treatment of Tinea Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Fungal Drugs for Treatment of Tinea Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Fungal Drugs for Treatment of Tinea Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Fungal Drugs for Treatment of Tinea Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Tianjin Lisheng Pharmaceuticals
  2. 6.1.1 Tianjin Lisheng Pharmaceuticals Company Information
  3. 6.1.2 Tianjin Lisheng Pharmaceuticals Business Overview
  4. 6.1.3 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Tianjin Lisheng Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  6. 6.1.5 Tianjin Lisheng Pharmaceuticals Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals
  14. 6.3.1 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Company Information
  15. 6.3.2 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Business Overview
  16. 6.3.3 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  18. 6.3.5 Shanghai Modern Hasen (Shangqiu) Pharmaceuticals Recent Developments
  19. 6.4 Shandong Qilu Pharmaceuticals
  20. 6.4.1 Shandong Qilu Pharmaceuticals Company Information
  21. 6.4.2 Shandong Qilu Pharmaceuticals Business Overview
  22. 6.4.3 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Shandong Qilu Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  24. 6.4.5 Shandong Qilu Pharmaceuticals Recent Developments
  25. 6.5 Shandong Luoxin Pharmaceuticals
  26. 6.5.1 Shandong Luoxin Pharmaceuticals Company Information
  27. 6.5.2 Shandong Luoxin Pharmaceuticals Business Overview
  28. 6.5.3 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Shandong Luoxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  30. 6.5.5 Shandong Luoxin Pharmaceuticals Recent Developments
  31. 6.6 Shandong Jingwei Pharmaceutical
  32. 6.6.1 Shandong Jingwei Pharmaceutical Company Information
  33. 6.6.2 Shandong Jingwei Pharmaceutical Business Overview
  34. 6.6.3 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Jingwei Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  36. 6.6.5 Shandong Jingwei Pharmaceutical Recent Developments
  37. 6.7 Sandoz
  38. 6.7.1 Sandoz Company Information
  39. 6.7.2 Sandoz Business Overview
  40. 6.7.3 Sandoz Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sandoz Fungal Drugs for Treatment of Tinea Product Portfolio
  42. 6.7.5 Sandoz Recent Developments
  43. 6.8 Johnson & Johnson
  44. 6.8.1 Johnson & Johnson Company Information
  45. 6.8.2 Johnson & Johnson Business Overview
  46. 6.8.3 Johnson & Johnson Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Johnson & Johnson Fungal Drugs for Treatment of Tinea Product Portfolio
  48. 6.8.5 Johnson & Johnson Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Fungal Drugs for Treatment of Tinea Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Jiangsu Zhiyuan Pharmaceutical
  56. 6.10.1 Jiangsu Zhiyuan Pharmaceutical Company Information
  57. 6.10.2 Jiangsu Zhiyuan Pharmaceutical Business Overview
  58. 6.10.3 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Jiangsu Zhiyuan Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  60. 6.10.5 Jiangsu Zhiyuan Pharmaceutical Recent Developments
  61. 6.11 Jiangsu Yunyang Group Pharmaceuticals
  62. 6.11.1 Jiangsu Yunyang Group Pharmaceuticals Company Information
  63. 6.11.2 Jiangsu Yunyang Group Pharmaceuticals Business Overview
  64. 6.11.3 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Jiangsu Yunyang Group Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  66. 6.11.5 Jiangsu Yunyang Group Pharmaceuticals Recent Developments
  67. 6.12 Hubei Hengan Fulin
  68. 6.12.1 Hubei Hengan Fulin Company Information
  69. 6.12.2 Hubei Hengan Fulin Business Overview
  70. 6.12.3 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Hubei Hengan Fulin Fungal Drugs for Treatment of Tinea Product Portfolio
  72. 6.12.5 Hubei Hengan Fulin Recent Developments
  73. 6.13 Hainan Kangzhi Pharmaceuticals
  74. 6.13.1 Hainan Kangzhi Pharmaceuticals Company Information
  75. 6.13.2 Hainan Kangzhi Pharmaceuticals Business Overview
  76. 6.13.3 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Hainan Kangzhi Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  78. 6.13.5 Hainan Kangzhi Pharmaceuticals Recent Developments
  79. 6.14 Harbin Sanlian Pharmaceuticals
  80. 6.14.1 Harbin Sanlian Pharmaceuticals Company Information
  81. 6.14.2 Harbin Sanlian Pharmaceuticals Business Overview
  82. 6.14.3 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Harbin Sanlian Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  84. 6.14.5 Harbin Sanlian Pharmaceuticals Recent Developments
  85. 6.15 Guilin Huaxin Pharmaceuticals
  86. 6.15.1 Guilin Huaxin Pharmaceuticals Company Information
  87. 6.15.2 Guilin Huaxin Pharmaceuticals Business Overview
  88. 6.15.3 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Guilin Huaxin Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  90. 6.15.5 Guilin Huaxin Pharmaceuticals Recent Developments
  91. 6.16 GSK
  92. 6.16.1 GSK Company Information
  93. 6.16.2 GSK Business Overview
  94. 6.16.3 GSK Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 GSK Fungal Drugs for Treatment of Tinea Product Portfolio
  96. 6.16.5 GSK Recent Developments
  97. 6.17 Chengdu Beite Pharmaceuticals
  98. 6.17.1 Chengdu Beite Pharmaceuticals Company Information
  99. 6.17.2 Chengdu Beite Pharmaceuticals Business Overview
  100. 6.17.3 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Chengdu Beite Pharmaceuticals Fungal Drugs for Treatment of Tinea Product Portfolio
  102. 6.17.5 Chengdu Beite Pharmaceuticals Recent Developments
  103. 6.18 Bayer
  104. 6.18.1 Bayer Company Information
  105. 6.18.2 Bayer Business Overview
  106. 6.18.3 Bayer Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Bayer Fungal Drugs for Treatment of Tinea Product Portfolio
  108. 6.18.5 Bayer Recent Developments
  109. 6.19 Ultratech India
  110. 6.19.1 Ultratech India Company Information
  111. 6.19.2 Ultratech India Business Overview
  112. 6.19.3 Ultratech India Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Ultratech India Fungal Drugs for Treatment of Tinea Product Portfolio
  114. 6.19.5 Ultratech India Recent Developments
  115. 6.20 Perrigo
  116. 6.20.1 Perrigo Company Information
  117. 6.20.2 Perrigo Business Overview
  118. 6.20.3 Perrigo Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Perrigo Fungal Drugs for Treatment of Tinea Product Portfolio
  120. 6.20.5 Perrigo Recent Developments
  121. 6.21 Padagis
  122. 6.21.1 Padagis Company Information
  123. 6.21.2 Padagis Business Overview
  124. 6.21.3 Padagis Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Padagis Fungal Drugs for Treatment of Tinea Product Portfolio
  126. 6.21.5 Padagis Recent Developments
  127. 6.22 Kaken Pharmaceutical
  128. 6.22.1 Kaken Pharmaceutical Company Information
  129. 6.22.2 Kaken Pharmaceutical Business Overview
  130. 6.22.3 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Kaken Pharmaceutical Fungal Drugs for Treatment of Tinea Product Portfolio
  132. 6.22.5 Kaken Pharmaceutical Recent Developments
  133. 6.23 Gufic Biosciences
  134. 6.23.1 Gufic Biosciences Company Information
  135. 6.23.2 Gufic Biosciences Business Overview
  136. 6.23.3 Gufic Biosciences Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Gufic Biosciences Fungal Drugs for Treatment of Tinea Product Portfolio
  138. 6.23.5 Gufic Biosciences Recent Developments
  139. 6.24 Galderma
  140. 6.24.1 Galderma Company Information
  141. 6.24.2 Galderma Business Overview
  142. 6.24.3 Galderma Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Galderma Fungal Drugs for Treatment of Tinea Product Portfolio
  144. 6.24.5 Galderma Recent Developments
  145. 6.25 Bausch Health
  146. 6.25.1 Bausch Health Company Information
  147. 6.25.2 Bausch Health Business Overview
  148. 6.25.3 Bausch Health Fungal Drugs for Treatment of Tinea Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Bausch Health Fungal Drugs for Treatment of Tinea Product Portfolio
  150. 6.25.5 Bausch Health Recent Developments
7 North America
  1. 7.1 North America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
  3. 7.3 North America Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
  3. 8.3 Europe Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
  3. 10.3 South America Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Fungal Drugs for Treatment of Tinea Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst